Whom to biopsy: prediagnostic risk stratification with biomarkers, nomograms, and risk calculators

S Loeb, H Dani - Urologic Clinics, 2017 - urologic.theclinics.com
Historically, prostate biopsy was performed because of a prostate-specific antigen (PSA)
level exceeding a specific threshold or suspicious findings on digital rectal examination …
被引用次数：26 相关文章

Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators

S Loeb, H Dani - The Urologic clinics of North America, 2017 - pubmed.ncbi.nlm.nih.gov
This article describes markers used for prostate biopsy decisions, including prostrate-
specific antigen (PSA), free PSA, the prostate health index, 4Kscore, PCA3, and …
[HTML] nih.gov

[HTML][HTML] Whom to Biopsy: Pre-Diagnostic Risk Stratification with Biomarkers, Nomograms and Risk Calculators

S Loeb, H Dani - The Urologic clinics of North America, 2017 - ncbi.nlm.nih.gov
Whom to Biopsy: Pre-Diagnostic Risk Stratification with Biomarkers, Nomograms and Risk
Calculators - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.

S Loeb, H Dani - The Urologic Clinics of North America, 2017 - europepmc.org
Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk
Calculators. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …

Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.

S Loeb, H Dani - The Urologic Clinics of North America, 2017 - europepmc.org
Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk
Calculators. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …